David Mehalick - 07 Dec 2023 Form 4 Insider Report for Coeptis Therapeutics Holdings, Inc. (COEP)

Role: CEO and President, Director, 10%+ Owner
Signature: /s/ David Mehalick
Issuer symbol: COEP
Transactions as of: 07 Dec 2023
Net transactions value: $0
Form type: 4
Filing time: 11 Dec 2023, 16:01:07 UTC
Previous filing: 31 Jan 2023
Next filing: 09 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COEP	Common Stock	Gift	$0	-700,000	-20%	$0.000000	2,757,561	07 Dec 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The listed shares were transferred to an estate planning trust that has an independent trustee, for the benefit of the Reporting Person's children and for no consideration. The Reporting Person does not serve as trustee of this trust nor does he have or share investment control over the listed shares held by this trust. The Reporting Person disclaims beneficial ownership of the shares held by the trust, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the listed shares for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.

Content

The listed shares were transferred to an estate planning trust that has an independent trustee, for the benefit of the Reporting Person's children and for no consideration. The Reporting Person does not serve as trustee of this trust nor does he have or share investment control over the listed shares held by this trust. The Reporting Person disclaims beneficial ownership of the shares held by the trust, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the listed shares for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.